Transpact Enterprises Ltd (TRANSPACT) — shareholding pattern, promoter holding, financials and share price
About Transpact Enterprises Ltd (TRANSPACT)
Transpact Enterprises Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as TRANSPACT and on the BSE under scrip code 542765. Its ISIN is INE06YD01010.
Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients [1]
Transpact Enterprises Limited is an innovative MedTech startup, providing therapeutic devices and rehabilitation services designed to assist specially-abled individuals.
The company is incubated by SINE, IIT Bombay, and is ISO 13485:2016 & ISO 9001:2015 certified, demonstrating its commitment to quality in medical devices.
Listed peers in Medical Equipment & Supplies: Shree Pacetronix Ltd, KMS Medisurgi Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd, Galaxy Medicare Ltd.
Valuation & Returns
At ₹170 a share, Transpact Enterprises Ltd (TRANSPACT) was valued at a price-to-earnings ratio of 77.3x against an industry P/E of 44.11x and a price-to-book of 17.13x on a book value of ₹11.68 per share. Solomo computes return on equity of 20.02% and return on capital employed of 17.04% from filed results.
- P/E
- 77.3x
- Industry P/E
- 44.11x
- P/B
- 17.13x
- EPS (TTM)
- ₹0.23
- Book value / share
- ₹11.68
- ROE
- 20.02%
- ROCE
- 17.04%
- ROA
- 13.7%
- Debt / equity
- 0.12x
- Dividend yield
- 0%
- EBITDA margin
- 72.22%
- 52-week range
- ₹119.55 – ₹297.5
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Transpact Enterprises Ltd (TRANSPACT) reported revenue of ₹0.18 crore, net profit of ₹0.09 crore and earnings per share of ₹2.33. That compares with revenue of ₹0.08 crore and net profit of ₹0.01 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.09 crore and net profit ₹0.04 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0.15 | 0.38 | 0 | 0.08 | 0.18 |
| Net profit (₹ cr) | -0.22 | -0.07 | -0.09 | 0.01 | 0.09 |
| EPS (₹) | -5.69 | -1.81 | -2.33 | 0.26 | 2.33 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | -18.07% | - |
| Profit growth | - | 111.11% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 16.16% of Transpact Enterprises Ltd (TRANSPACT). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2019.
Largest disclosed public shareholders in Mar 2026: VISHAL MAHESH WAGHELA 18.36%, ONVO AQUARRIUS PRIVATE LIMITED 3.49%, KAVITA KUMAR SANTOSH 2.84%, PRIYA SAINI 2.59%, HUF 2.59%, XTENDED BUSINESS REPORTING LIMITED 2.33%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 16.16% | - | - | - | 83.84% |
| Sep 2025 | 0.13% | - | - | - | 99.87% |
| Mar 2025 | 16.16% | - | - | - | 83.84% |
| Sep 2024 | 16.16% | - | - | - | 83.84% |
| Mar 2024 | 18.23% | - | - | - | 81.77% |
| Sep 2023 | 32.2% | - | - | - | 67.8% |
| Mar 2023 | 32.63% | - | - | - | 67.37% |
| Sep 2022 | 45.89% | - | - | - | 54.11% |